Rucaparib cocrystal: Improved solubility and bioavailability over camsylate

Xia, MY; Jiang, YH; Cheng, YX; Dai, WJ; Rong, XY; Zhu, BQ; Mei, XF

Zhu, BQ; Mei, XF (通讯作者)，Chinese Acad Sci, Shanghai Inst Mat Med, Pharmaceut Analyt & Solid State Chem Res Ctr, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China.

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2023; 631 ():

Abstract

Rucaparib (Ruc) is a drug used to treat advanced ovarian cancer associated with deleterious BRCA mutations. Its commercial form, the camsylate salt (R......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索